| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2002;39:149.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
With Different Pressor Dependencies in Rats
From the Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine (T.A., N.I., S.-I.U., M.O., R.N.); and the Discovery Research Laboratory, Tanabe Seiyaku Company Limited (N.O.), Tokyo, Japan.
Correspondence to Nobukazu Ishizaka, MD, PhD, Department of Cardiovascular Medicine, University of Tokyo, Graduate School of Medicine, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail nobuishizka-tky{at}umin.ac.jp
We investigated the extent of oxidative stress evoked in the hypertensive rat by measuring plasma levels of 8-epi-prostaglandin F2
(8-epi-PGF2
), a marker of in vivo oxidative stress. Administration of angiotensin (Ang) II and norepinephrine at doses of 0.7 and 2.8 mg · kg-1 · d-1, respectively, resulted in similar significant elevations in plasma levels of 8-epi-PGF2
. A 7-day infusion of Ang II at a nonpressor dose, but not norepinephrine at a nonpressor dose, also increased plasma levels of 8-epi-PGF2
. The norepinephrine-induced increase in 8-epi-PGF2
levels could be completely normalized by 3 different classes of antihypertensive drugs: prazosin, an
-adrenergic receptor blocker; hydralazine, a nonspecific vasodilator; and losartan, a specific angiotensin type 1 (AT1) receptor antagonist. This finding suggests that the norepinephrine-induced increase is a pressor-dependent event. In contrast, among these antihypertensive drugs, only losartan was effective in inhibiting the Ang IIinduced increase in plasma 8-epi-PGF2
, suggesting that Ang II increases plasma levels of 8-epi-PGF2
in both a pressor-independent and an AT1 receptordependent manner. In summary, continuous infusion of both Ang II and norepinephrine potently increases plasma levels of 8-epi-PGF2
and thus in vivo oxidative stress. Ang II and norepinephrine seem to induce this increase in 8-epi-PGF2
via mechanisms with different pressor dependencies.
Key Words: angiotensin II AT1 receptor oxidative stress isoprostanes catecholamine
This article has been cited by other articles:
![]() |
C. Vecchione, D. Carnevale, A. Di Pardo, M. T. Gentile, A. Damato, G. Cocozza, G. Antenucci, G. Mascio, U. Bettarini, A. Landolfi, et al. Pressure-Induced Vascular Oxidative Stress Is Mediated Through Activation of Integrin-Linked Kinase 1/{beta}PIX/Rac-1 Pathway Hypertension, November 1, 2009; 54(5): 1028 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Moreau, A. R. DePaulis, K. M. Gavin, and D. R. Seals Oxidative stress contributes to chronic leg vasoconstriction in estrogen-deficient postmenopausal women J Appl Physiol, March 1, 2007; 102(3): 890 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Luther, J. V. Gainer, L. J. Murphey, C. Yu, D. E. Vaughan, J. D. Morrow, and N. J. Brown Angiotensin II Induces Interleukin-6 in Humans Through a Mineralocorticoid Receptor-Dependent Mechanism Hypertension, December 1, 2006; 48(6): 1050 - 1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishizaka, K. Saito, I. Mori, G. Matsuzaki, M. Ohno, and R. Nagai Iron Chelation Suppresses Ferritin Upregulation and Attenuates Vascular Dysfunction in the Aorta of Angiotensin II-Infused Rats Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2282 - 2288. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Moreau, K. M. Gavin, A. E. Plum, and D. R. Seals Ascorbic Acid Selectively Improves Large Elastic Artery Compliance in Postmenopausal Women Hypertension, June 1, 2005; 45(6): 1107 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishizaka, K. Saito, E. Noiri, M. Sata, H. Ikeda, A. Ohno, J. Ando, I. Mori, M. Ohno, and R. Nagai Administration of ANG II induces iron deposition and upregulation of TGF-{beta}1 mRNA in the rat liver Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R1063 - R1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Saito, N. Ishizaka, T. Aizawa, M. Sata, N. Iso-o, E. Noiri, I. Mori, M. Ohno, and R. Nagai Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-{beta}1 in the heart Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1836 - H1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ungvari, A. Csiszar, P. M. Kaminski, M. S. Wolin, and A. Koller Chronic High Pressure-Induced Arterial Oxidative Stress: Involvement of Protein Kinase C-Dependent NAD(P)H Oxidase and Local Renin-Angiotensin System Am. J. Pathol., July 1, 2004; 165(1): 219 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ungvari, A. Csiszar, A. Huang, P. M. Kaminski, M. S. Wolin, and A. Koller High Pressure Induces Superoxide Production in Isolated Arteries Via Protein Kinase C-Dependent Activation of NAD(P)H Oxidase Circulation, September 9, 2003; 108(10): 1253 - 1258. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |